Financial Accounts23 Jul 2022 18:17
Just been trying to understand the final results statement to 21 Dec 2021:
"Revaluation of Deferred Consideration... As a result of revaluing deferred consideration related to the acquisition of Itaconix Corporation in 2016, per note 17, there was an exceptional non-cash income of $1.6m in 2021, which offsets the exceptional non-cash expense of $0.3m (excluding foreign exchange) from 2020. In addition to the revaluation of the liability the Group issued 1,923,389 shares to certain Sellers of Itaconix Corporation on 12 April 2021 in settlement of the contingent consideration payment for 2020."
Is this now concluded as per note below? I am not sure where the not 17 is which is referred to above - anyone know?
PARTIAL EXTRACT FROM PRELIM ACCOUNTS TO 21 DEC 2016: "The Group issued 6,305,050 ordinary shares of nominal value 1p each as consideration for a 100% interest in Itaconix
Corporation. ... As part of the purchase agreement with the previous owners of Itaconix Corporation, a contingent ... deferred performance related consideration will be payable to the Itaconix Corporation shareholders, subject to the achievement of certain growth targets for the calendar years 2017 to 2020, based on 50% of incremental annual net sales value above $3m in 2017 and in excess of the prior year for 2018 to 2020 inclusive.
The deferred performance related consideration is capped at $6m in aggregate. Such deferred performance consideration, if any, will be satisfied annually entirely in ordinary shares of Itaconix plc "